Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Disruption of Cerebrospinal Fluid Flow through the Olfactory System May Contribute to Alzheimer's Disease Pathogenesis.

Ethell DW.

J Alzheimers Dis. 2014 Jan 1;41(4):1021-30. doi: 10.3233/JAD-130659.

PMID:
24769627
[PubMed - in process]
2.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
[PubMed - indexed for MEDLINE]
3.

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease.

Johanson CE, Duncan JA 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD.

Cerebrospinal Fluid Res. 2008 May 14;5:10. doi: 10.1186/1743-8454-5-10.

PMID:
18479516
[PubMed]
Free PMC Article
4.

Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.

Hock C, Golombowski S, Müller-Spahn F, Naser W, Beyreuther K, Mönning U, Schenk D, Vigo-Pelfrey C, Bush AM, Moir R, Tanzi RE, Growdon JH, Nitsch RM.

Eur Neurol. 1998;39(2):111-8.

PMID:
9520072
[PubMed - indexed for MEDLINE]
5.

How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?

Weller RO.

J Pathol. 2001 May;194(1):1-3.

PMID:
11329133
[PubMed - indexed for MEDLINE]
6.

Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.

Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, Polson CT, Wang J, Roberts SB, Hendrick JP, Anderson JJ, Loy JK, Denton R, Verdoorn TA, Smith DW, Felsenstein KM.

J Pharmacol Exp Ther. 2005 Feb;312(2):635-43. Epub 2004 Sep 27.

PMID:
15452193
[PubMed - indexed for MEDLINE]
Free Article
7.

Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis.

Wostyn P, van Dam D, Audenaert K, de Deyn PP.

J Neurogenet. 2011 Dec;25(4):195-200. doi: 10.3109/01677063.2011.620191. Epub 2011 Oct 24.

PMID:
22023247
[PubMed - indexed for MEDLINE]
8.

[Characterization of amyloid beta protein species in the plasma, cerebrospinal fluid and brains of patients with Alzheimer's disease].

Tamaoka A.

Nihon Ronen Igakkai Zasshi. 1998 Apr;35(4):273-7. Japanese.

PMID:
9643008
[PubMed - indexed for MEDLINE]
Free Article
9.

Cerebrospinal fluid outflow resistance in sheep: impact of blocking cerebrospinal fluid transport through the cribriform plate.

Silver I, Kim C, Mollanji R, Johnston M.

Neuropathol Appl Neurobiol. 2002 Feb;28(1):67-74.

PMID:
11849565
[PubMed - indexed for MEDLINE]
10.

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.

Santos AN, Ewers M, Minthon L, Simm A, Silber RE, Blennow K, Prvulovic D, Hansson O, Hampel H.

J Alzheimers Dis. 2012;29(1):171-6. doi: 10.3233/JAD-2012-111361.

PMID:
22214781
[PubMed - indexed for MEDLINE]
11.

The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.

Sancesario GM, Cencioni MT, Esposito Z, Borsellino G, Nuccetelli M, Martorana A, Battistini L, Sorge R, Spalletta G, Ferrazzoli D, Bernardi G, Bernardini S, Sancesario G.

J Alzheimers Dis. 2012;31(4):865-78. doi: 10.3233/JAD-2012-120211.

PMID:
22717612
[PubMed - indexed for MEDLINE]
12.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

PMID:
19319544
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.

Yamagishi S, Nakamura K, Inoue H, Kikuchi S, Takeuchi M.

Med Hypotheses. 2005;64(6):1205-7.

PMID:
15823718
[PubMed - indexed for MEDLINE]
14.

Quantification of cerebrospinal fluid transport across the cribriform plate into lymphatics in rats.

Nagra G, Koh L, Zakharov A, Armstrong D, Johnston M.

Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1383-9. Epub 2006 Jun 22.

PMID:
16793937
[PubMed - indexed for MEDLINE]
15.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
[PubMed - indexed for MEDLINE]
16.

Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease.

Wostyn P, Van Dam D, Audenaert K, De Deyn PP.

Int J Alzheimers Dis. 2011;2011:617420. doi: 10.4061/2011/617420. Epub 2011 May 26.

PMID:
21660211
[PubMed]
Free PMC Article
17.

APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Crews L, Rockenstein E, Masliah E.

Brain Struct Funct. 2010 Mar;214(2-3):111-26. doi: 10.1007/s00429-009-0232-6. Epub 2009 Nov 29. Review.

PMID:
20091183
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.

Brys M, Glodzik L, Mosconi L, Switalski R, De Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R, Pratico D, Wallin A, Zetterberg H, Tsui WH, Rusinek H, Blennow K, de Leon MJ.

J Alzheimers Dis. 2009;16(2):351-62. doi: 10.3233/JAD-2009-0968.

PMID:
19221425
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Age-related changes in brain extracellular space affect processing of amyloid-β peptides in Alzheimer's disease.

Bondareff W.

J Alzheimers Dis. 2013;35(1):1-6. doi: 10.3233/JAD-122305. Review.

PMID:
23364138
[PubMed - indexed for MEDLINE]
20.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Review.

PMID:
22503777
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk